ARHGAP25 (Gene)

Synonyms:ARHGAP25, ENTREZ:9938, HEL-S-308, HGNC:28951, KAIA0053, MIM:610587, NM_001007231, NM_001166276, NM_001166277, NM_001364819, NM_001364820, NM_001364821, NM_014882, NP_001007232, NP_001159748, NP_001159749, NP_001351748, NP_001351749, NP_001351750, NP_055697, Rho GTPase activating protein 25, XM_011533207, XM_011533208, XM_011533209, XM_011533210, XM_017005423, XM_017005424, XM_017005425, XM_017005426, XM_017005427, XM_017005428, XP_011531509, XP_011531510, XP_011531511, XP_011531512, XP_016860912, XP_016860913, XP_016860914, XP_016860915, XP_016860916, XP_016860917
Omim:OMIM:610587
Id:a4061911-be0f-5fb6-b9cd-f65e7fb29414
Hgnc:HGNC:28951
Entrez:9938
Description:Rho GTPase activating protein 25
ARHGAPs, such as ARHGAP25, encode negative regulators of Rho GTPases (see ARHA; MIM 165390), which are implicated in actin remodeling, cell polarity, and cell migration (Katoh and Katoh, 2004 [PubMed 15254788]).[supplied by OMIM, Mar 2008]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View ARHGAP25's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with ARHGAP25.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using ARHGAP25.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for ARHGAP25.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with ARHGAP25.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.